AbbVie Bails On Harpoon’s Multiple Myeloma Drug Amid Highly Competitive Environment

 
• By Alaric DeArment
  
AbbVie decided not to exercise its option for Harpoon's multiple myeloma drug candidate • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer